Free Trial

Qualigen Therapeutics (QLGN) News Today

Qualigen Therapeutics logo
$4.34 +0.47 (+12.14%)
(As of 01:30 PM ET)
Qualigen announces $4.5M private placement of Preferred Shares
Qualigen Therapeutics Appoints Graydon Bensler to Board
Qualigen Therapeutics trading halted, news pending
Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split
Qualigen Therapeutics, Inc. Announces management changes.
Why Is Qualigen (QLGN) Stock Up 141% Today?
Qualigen Therapeutics Inc Ordinary Shares QLGN
Qualigen Therapeutics Inc (QLGN)
QLGN: Dosing Begins in Phase 1 Trial of QN-302…
Qualigen Therapeutics Inc (7R9.DU)
QLGN: Data for Pan-RAS Platform Presented at ASCO…
QLGN: IND for QN-302 to be Submitted in Mid-2023…
Get Qualigen Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for QLGN and its competitors with MarketBeat's FREE daily newsletter.

Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

QLGN Media Mentions By Week

QLGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

QLGN
News Sentiment

0.50

0.47

Average
Medical
News Sentiment

QLGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

QLGN Articles
This Week

3

0

QLGN Articles
Average Week

Get Qualigen Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for QLGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:QLGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners